Indian Pharma Lobby Calls For Re-examination Of 81 MNC Drug Patents
This article was originally published in PharmAsia News
MUMBAI - As Indian companies battle multinational drug giants for patent rights, the Indian Pharmaceutical Alliance - an association that represents top Indian drug companies - wrote to the Union Ministry of Commerce and Industry Feb. 14 that a large number of pharmaceutical patents granted over the last four years are granted to new forms of known substances and combinations of old drugs
You may also be interested in...
MUMBAI - Swiss drug maker Roche has gained a significant lead against two non-government organizations in its fight over patents of anti-infection drug Valcyte (valgancyclovir) after India's Controller of Patents rejected their pleas for pre-grant opposition
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).